New Emerging Therapeutic Strategies Based on Manipulation of the Redox Regulation Against Therapy Resistance in Cancer
Antioxidants & Redox Signaling · 06.11.2024
DOI: 10.1089/ars.2023.0491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 06.11.2024. Verfasst von Ahmad Nazari und 10 weiteren Autor:innen. Beteiligte Einrichtung: Tehran University of Medical Science, Tehran, Iran. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 305 Literaturangaben.
Abstract (Originalsprache)
Background
Resistance to standard therapeutic methods, including chemotherapy, immunotherapy, and targeted therapy, remains a critical challenge in effective cancer treatment. Redox homeostasis modification has emerged as a promising approach to address medication resistance.
Objective
This review aims to explore the mechanisms of redox alterations and signaling pathways contributing to treatment resistance in cancer.
Methods
In this study, a comprehensive review of the molecular mechanisms underlying drug resistance governed by redox signaling was conducted. Emphasis was placed on understanding how tumor cells manage increased reactive oxygen species (ROS) levels through upregulated antioxidant systems, enabling resistance across multiple therapeutic pathways.
Results
Key mechanisms identified include alterations in drug efflux, target modifications, metabolic changes, enhanced DNA damage repair, stemness preservation, and tumor microenvironment remodeling. These pathways collectively facilitate tumor cells' adaptive response and resistance to various cancer treatments.
Conclusion
Developing a detailed understanding of the interrelationships between these redox-regulated mechanisms and therapeutic resistance holds potential to improve treatment effectiveness, offering valuable insights for both fundamental and clinical cancer research. Antioxid. Redox Signal. 00, 000–000.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tehran University of Medical Science, Tehran, Iran.
- Department of Chemical Engineering, Fouman Faculty of Engineering, College of Engineering, University of Tehran, Tehran, Iran.
- Department of Biotechnology, Faculty of Applied Ecology, Agricultural Science and Biotechnology, Campus Hamar, Norway.
- Department of Cardiology, Internal Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xian, Shaanxi Province, 710061, China.
- Master 1 Bio-Santé-Parcours Toulouse Graduate School of Cancer, Ageing and Rejuvenation (CARe), Université Toulouse III-Paul Sabatier, Toulouse, France.
- General Physician in Medicine Program,General Doctorate Degree of Yazd Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
ORCID-Profile: Amir Reza Aref
Zitieren
APA
Nazari, A., Osati, P., Seifollahy Fakhr, S., Faghihkhorasani, F., Ghanaatian, M., Faghihkhorasani, F., Rezaei-Tazangi, F., Pazhouhesh Far, N., Shourideh, A., Ebrahimi, N., & Aref, A. R. (2024). New Emerging Therapeutic Strategies Based on Manipulation of the Redox Regulation Against Therapy Resistance in Cancer. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2023.0491
Vancouver
Nazari A, Osati P, Seifollahy Fakhr S, Faghihkhorasani F, Ghanaatian M, Faghihkhorasani F, et al. New Emerging Therapeutic Strategies Based on Manipulation of the Redox Regulation Against Therapy Resistance in Cancer. Antioxidants & Redox Signaling. 2024. doi:10.1089/ars.2023.0491
BibTeX
@article{Nazari2024,
author = {Nazari, Ahmad and Osati, Parisa and Seifollahy Fakhr, Siavash and Faghihkhorasani, Ferdos and Ghanaatian, Masoud and Faghihkhorasani, Fereshteh and Rezaei-Tazangi, Fatemeh and Pazhouhesh Far, Nazanin and Shourideh, Amir and Ebrahimi, Nasim and Aref, Amir Reza},
title = {New Emerging Therapeutic Strategies Based on Manipulation of the Redox Regulation Against Therapy Resistance in Cancer},
journal = {Antioxidants & Redox Signaling},
year = {2024},
doi = {10.1089/ars.2023.0491}
}
EUVIMED